| 1997 |
GS15 (BET1L) is a 15 kDa integral membrane protein highly enriched in Golgi membranes that behaves biochemically as a SNARE protein, identified as a mammalian homolog of yeast Bet1p involved in vesicular transport. |
Affinity-purified polyclonal antibodies, indirect immunofluorescence microscopy, biochemical fractionation/characterization |
The Journal of biological chemistry |
Medium |
9242691
|
| 2002 |
GS15 (BET1L) localizes to medial-cisternae of the Golgi apparatus (not the IC/ER exit sites), exists in a distinct SNARE complex with syntaxin 5, GS28, and Ykt6 (but not with ER-to-Golgi-exclusive SNAREs), co-immunoprecipitates with COPI coat components from Golgi extracts, and is essential for normal Golgi structure — its knockdown redistributes Golgi markers into small dotty/diffuse patterns. |
Immuno-electron microscopy, co-immunoprecipitation, siRNA knockdown, overexpression of dominant-negative mutants, indirect immunofluorescence |
Molecular biology of the cell |
High |
12388752
|
| 2004 |
GS15 (BET1L) functions as part of the syntaxin 5/Ykt6/GS28/GS15 SNARE complex specifically in transport from the early/recycling endosome (EE/RE) to the trans-Golgi network (TGN); antibody inhibition of GS15 blocks STxB transport, and siRNA knockdown of GS15 blocks recombinant STxB transport in HeLa cells. GS15 and Ykt6 redistribute from Golgi to endosomes when the recycling endosome is perturbed by SNX3-overexpression, suggesting cycling between endosomes and Golgi. |
In vitro transport assay with Shiga toxin B subunit, antibody inhibition, siRNA knockdown, immunofluorescence with SNX3 overexpression |
Molecular biology of the cell |
High |
15215310
|
| 2016 |
COG lobe B sub-complex (COG5-8) physically interacts with v-SNARE GS15 (BET1L) on vesicle-like structures at the Golgi, as demonstrated by super-resolution microscopy showing spatial separation of COG lobe A (on Golgi stacks) and lobe B (on vesicle-like structures where it contacts GS15). |
Super-resolution microscopy, co-immunoprecipitation/interaction assays, dominant-negative COG constructs |
Scientific reports |
Medium |
27385402
|
| 2021 |
Bet1L (BET1L) protein is localized to the basal lamina of the neuromuscular junction (NMJ) in rat skeletal muscle, and its expression decreases over time in the SOD1G93A ALS rat model, beginning early in disease progression. |
Immunofluorescence/immunohistochemistry of rat NMJ tissue, RNA sequencing of iPSC-derived myocytes and ALS rat hindlimb muscle |
Experimental neurology |
Low |
34310943
|
| 2024 |
GS15 (BET1L) undergoes partial mislocalization and degradation upon acute GARP complex disruption (rapid VPS54 depletion via mAID degron), placing GS15 downstream of GARP-dependent vesicle tethering at the TGN. |
mAID degron-mediated acute protein degradation, immunofluorescence, western blot |
bioRxivpreprint |
Low |
|
| 2025 |
Muscle-specific Bet1L (BET1L) knockdown via siRNA injection into hindlimb muscle of ALS (SOD1G93A) and wild-type rats caused increased denervated NMJs, decreased motor neuron size in lumbar spinal cord, and impaired hindlimb motor function; effects were more severe in ALS rats, establishing a functional role for Bet1L in NMJ maintenance. |
In vivo siRNA knockdown in rat hindlimb muscle, NMJ immunohistochemistry, motor neuron morphometry, behavioral motor function tests |
Frontiers in neuroscience |
Medium |
39896335
|
| 2023 |
A SNP (rs11245997) in the BET1L 3'UTR disrupts miR-140-3p binding and reduces m6A modification (mediated by METTL14/WTAP/ALKBH5), leading to upregulated BET1L expression that promotes colorectal cancer cell growth in vitro and in vivo; BET1L expression was associated with regulation of HSD17B7, CYP27B1, and COMT in the steroid biosynthesis pathway. |
Luciferase reporter assays for miRNA binding, m6A methylation assays, RNA-seq pathway analysis, in vitro proliferation assays, in vivo xenograft models, miR-140-3p overexpression rescue |
Cancer research |
Medium |
37115853
|